Back to top
more

Stryker (SYK)

(Delayed Data from NYSE)

$328.45 USD

328.45
1,589,324

+1.82 (0.56%)

Updated May 3, 2024 04:00 PM ET

After-Market: $328.52 +0.07 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

Should You Sell Stryker (SYK) Stock Before Earnings?

Stryker (SYK) might report a beat in the to be reported quarter on the back of its favorable Zacks Rank and positive Earnings ESP.

    Medical Product Stocks Earnings on Apr 25: SYK, EW, LH

    Medical is one of the broader sectors among the 16 Zacks sectors that are expected to report earnings growth in the first quarter.

      Will Stryker (SYK) Deliver a Beat this Earnings Season?

      Stryker Corporation (SYK), a leading player in the medical technology space, is set to report first-quarter 2017 results on Apr 25 after the bell.

        Stryker Launches MAKO Robotic-Arm for Knee Anthroplasty

        Stryker Corporation (SYK) recently announced the commercial launch of a robotic-arm assisted total knee arthroplasty application based on its flagship MAKO System.

          Why Is Stryker Corp (SYK) Up 5% Since the Last Earnings Report?

          Stryker Corp (SYK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

            Stryker (SYK) Beats Q4 Earnings, Provides FY17 Guidance

            Maintaining its streak of positive earnings surprises, Stryker Corp (SYK) reported adjusted earnings of $1.78 per share in the fourth quarter of 2016, which comfortably beat the Zacks Consensus Estimate by 2 cents.

              Should You Sell Stryker (SYK) Before Earnings?

              Investors are always looking for stocks that are poised to beat at earnings season and Stryker Corporation (SYK) may be one such company.

                Medical Product Stocks Q4 Earnings Roster: SYK, ISRG, RMD

                Medical is one of the broader sectors among the 16 Zacks sectors that is expected to report earnings growth in the fourth quarter.

                  The Zacks Analyst Blog Highlights: Intuitive Surgical, Stryker and Hologic

                  The Zacks Analyst Blog Highlights: Intuitive Surgical, Stryker and Hologic

                    Stryker (SYK): Can It Post a Beat this Earnings Season?

                    Delving deeper into the fundamentals of Stryker Corporation (SYK), we expect the stock to beat earnings estimates this quarter.

                      3 Medical Device Stocks Likely to Beat Earnings Estimates

                      The likely revocation of the 2.3% medical device excise tax is going to be a big bonus for both the behemoths and small players.

                        Stryker (SYK) to Pay for Rejuvenate and ABG II Modular-Neck

                        Stryker Corporation (SYK) announced that it has reached an agreement to compensate patients for Rejuvenate and ABG II Modular-Neck surgeries done prior to Dec 19, 2016.

                          Sheraz Mian headshot

                          Top Research Reports for Amazon, Ford & Dow Chemical

                          Today's Research Daily features new research reports on 16 major stocks, including Amazon (AMZN), Dow Chemical (DOW) and Ford (F).

                            Sheraz Mian headshot

                            Fresh Research Reports For Intel (INTC), AT&T (T) & Others

                            Today's must-read reports are for Intel (INTC), Biogen (BIIB) and AT&T (T).

                              David Bartosiak headshot

                              5 Skyrocketing Momentum Stocks

                              Five red hot momentum stocks breaking out to new highs

                                MedTech Industry Stock Outlook - Dec. 2015

                                While the global economy has been on a rollercoaster ride over the past quarter, the MedTech sector has not only held its own, but maintained a stable uptrend.

                                  MedTech Industry Stock Outlook - Dec. 2015

                                  While the global economy has been on a rollercoaster ride over the past quarter, the MedTech sector has not only held its own, but maintained a stable uptrend.

                                    Should You Buy Evolving Trends in Medical Devices?

                                    Given the U.S. government's pushback on tax-dodging, we expected some sloth to creep into the medical device space as far as M&As are concerned. But to our surprise, M&A activity worldwide has remained fairly stable.

                                      David Bartosiak headshot

                                      Momentum Stock Market Game Plan

                                      Momentum Stock Strategist David Bartosiak gives Terry Ruffolo the stock market game plan for today

                                        MedTech Industry Stock Outlook - July/Aug 2015

                                        Recently released government data showed that about 16.4 million uninsured people have gained health insurance coverage since the enactment of the Affordable Care Act five years back.

                                          MedTech Industry Stock Outlook - July/Aug 2015

                                          Recently released government data showed that about 16.4 million uninsured people have gained health insurance coverage since the enactment of the Affordable Care Act five years back.

                                            David Bartosiak headshot

                                            3 Best Stocks in the Market Today

                                            Stryker and 2 other hard hitting stock buys

                                              MedTech M&As Continue Regardless of Tax Scenarios

                                              MedTech stalwarts are not expected to shy away from hostile acquisition bids this year.